Literature DB >> 18634566

Adenosine dysfunction in astrogliosis: cause for seizure generation?

Tianfu Li1, Jing Quan Lan, Bertil B Fredholm, Roger P Simon, Detlev Boison.   

Abstract

Epilepsy is characterized by both neuronal and astroglial dysfunction. The endogenous anticonvulsant adenosine, the level of which is largely controlled by astrocytes, might provide a crucial link between astrocyte and neuron dysfunction in epilepsy. Here we have studied astrogliosis, a hallmark of the epileptic brain, adenosine dysfunction and the emergence of spontaneous seizures in a comprehensive approach that includes a new mouse model of focal epileptogenesis, mutant mice with altered brain levels of adenosine, and mice lacking adenosine A1 receptors. In wild-type mice, following a focal epileptogenesis-precipitating injury, astrogliosis, upregulation of the adenosine-removing astrocytic enzyme adenosine kinase (ADK), and spontaneous seizures coincide in a spatio-temporally restricted manner. Importantly, these spontaneous seizures are mimicked by untreated transgenic mice that either overexpress ADK in brain or lack A1 receptors. Conversely, mice with reduced ADK in the forebrain do not develop either astrogliosis or spontaneous seizures. Our studies define ADK as a crucial upstream regulator of A1 receptor-mediated modulation of neuronal excitability, and support the ADK hypothesis of epileptogenesis in which upregulation of ADK during astrogliosis provides a crucial link between astrocyte and neuron dysfunction in epilepsy. These findings define ADK as rational target for therapeutic intervention.

Entities:  

Year:  2007        PMID: 18634566      PMCID: PMC2561997          DOI: 10.1017/S1740925X0800015X

Source DB:  PubMed          Journal:  Neuron Glia Biol        ISSN: 1740-925X


  66 in total

1.  An astrocytic basis of epilepsy.

Authors:  Guo-Feng Tian; Hooman Azmi; Takahiro Takano; Qiwu Xu; Weiguo Peng; Jane Lin; NancyAnn Oberheim; Nanhong Lou; Xiaohai Wang; H Ronald Zielke; Jian Kang; Maiken Nedergaard
Journal:  Nat Med       Date:  2005-08-14       Impact factor: 53.440

2.  Adenosine A1 receptors are crucial in keeping an epileptic focus localized.

Authors:  Denise E Fedele; Tianfu Li; Jing Q Lan; Bertil B Fredholm; Detlev Boison
Journal:  Exp Neurol       Date:  2006-06-05       Impact factor: 5.330

Review 3.  Astrocyte control of synaptic transmission and neurovascular coupling.

Authors:  Philip G Haydon; Giorgio Carmignoto
Journal:  Physiol Rev       Date:  2006-07       Impact factor: 37.312

4.  Correlations between granule cell physiology and bioenergetics in human temporal lobe epilepsy.

Authors:  Anne Williamson; Peter R Patrylo; Jullie Pan; Dennis D Spencer; Hoby Hetherington
Journal:  Brain       Date:  2005-02-23       Impact factor: 13.501

5.  Calcium oscillations in neocortical astrocytes under epileptiform conditions.

Authors:  Ayumu Tashiro; Jesse Goldberg; Rafael Yuste
Journal:  J Neurobiol       Date:  2002-01

6.  Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate.

Authors:  J D Rothstein; M Dykes-Hoberg; C A Pardo; L A Bristol; L Jin; R W Kuncl; Y Kanai; M A Hediger; Y Wang; J P Schielke; D F Welty
Journal:  Neuron       Date:  1996-03       Impact factor: 17.173

Review 7.  Cell and gene therapies in epilepsy--promising avenues or blind alleys?

Authors:  Wolfgang Löscher; Manuela Gernert; Uwe Heinemann
Journal:  Trends Neurosci       Date:  2008-01-16       Impact factor: 13.837

Review 8.  The concentrative nucleoside transporter family, SLC28.

Authors:  Jennifer H Gray; Ryan P Owen; Kathleen M Giacomini
Journal:  Pflugers Arch       Date:  2003-07-11       Impact factor: 3.657

9.  Bim regulation may determine hippocampal vulnerability after injurious seizures and in temporal lobe epilepsy.

Authors:  Sachiko Shinoda; Clara K Schindler; Robert Meller; Norman K So; Tomohiro Araki; Akitaka Yamamoto; Jing-Quan Lan; Waro Taki; Roger P Simon; David C Henshall
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

10.  Evidence for a substrate cycle between AMP and adenosine in isolated hepatocytes.

Authors:  F Bontemps; G Van den Berghe; H G Hers
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

View more
  51 in total

1.  Nonsynaptic communication through ATP release from volume-activated anion channels in axons.

Authors:  R Douglas Fields; Yingchun Ni
Journal:  Sci Signal       Date:  2010-10-05       Impact factor: 8.192

2.  Adenosine kinase as a target for therapeutic antisense strategies in epilepsy.

Authors:  Panos Theofilas; Sukhmani Brar; Kerry-Ann Stewart; Hai-Ying Shen; Ursula S Sandau; David Poulsen; Detlev Boison
Journal:  Epilepsia       Date:  2011-01-28       Impact factor: 5.864

3.  Adenosine dysfunction and adenosine kinase in epileptogenesis.

Authors:  Detlev Boison
Journal:  Open Neurosci J       Date:  2010-01-01

Review 4.  Translational potential of astrocytes in brain disorders.

Authors:  Alexei Verkhratsky; Luca Steardo; Vladimir Parpura; Vedrana Montana
Journal:  Prog Neurobiol       Date:  2015-09-16       Impact factor: 11.685

Review 5.  Adenosine augmentation therapies (AATs) for epilepsy: prospect of cell and gene therapies.

Authors:  Detlev Boison
Journal:  Epilepsy Res       Date:  2009-05-09       Impact factor: 3.045

6.  Human mesenchymal stem cell grafts engineered to release adenosine reduce chronic seizures in a mouse model of CA3-selective epileptogenesis.

Authors:  Tianfu Li; Gaoying Ren; David L Kaplan; Detlev Boison
Journal:  Epilepsy Res       Date:  2009-02-12       Impact factor: 3.045

Review 7.  International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update.

Authors:  Bertil B Fredholm; Adriaan P IJzerman; Kenneth A Jacobson; Joel Linden; Christa E Müller
Journal:  Pharmacol Rev       Date:  2011-02-08       Impact factor: 25.468

Review 8.  Adenosine hypothesis of schizophrenia--opportunities for pharmacotherapy.

Authors:  Detlev Boison; Philipp Singer; Hai-Ying Shen; Joram Feldon; Benjamin K Yee
Journal:  Neuropharmacology       Date:  2011-02-17       Impact factor: 5.250

Review 9.  Glial adenosine kinase--a neuropathological marker of the epileptic brain.

Authors:  Eleonora Aronica; Ursula S Sandau; Anand Iyer; Detlev Boison
Journal:  Neurochem Int       Date:  2013-02-04       Impact factor: 3.921

10.  Opiate-induced changes in brain adenosine levels and narcotic drug responses.

Authors:  M Wu; P Sahbaie; M Zheng; R Lobato; D Boison; J D Clark; G Peltz
Journal:  Neuroscience       Date:  2012-10-22       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.